Skip to main content
Erschienen in: Der Internist 6/2014

01.06.2014 | Schwerpunkt

Ganzheitliche Behandlung der chronischen Herzinsuffizienz

verfasst von: C. Feldmann, G. Ertl, Prof. Dr. C.E. Angermann

Erschienen in: Die Innere Medizin | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die zunehmende Prävalenz und steigende krankheitsbedingte Kosten machen die chronische Herzinsuffizienz zu einer wachsenden sozioökonomischen Herausforderung. Nur durch ein therapeutisches Zusammenwirken von leitliniengerechter Herzinsuffizienztherapie und ganzheitlicher Patientenbetreuung können Mortalität, Morbidität, Leistungsfähigkeit und Lebensqualität verbessert werden. Eine ganzheitliche Patientenversorgung beinhaltet neben der medikamentösen und chirurgischen Therapie die Berücksichtigung von Komorbiditäten und individuellen Bedürfnissen, Lebensstilberatung und multidisziplinäre Managementprogramme bei Hochrisikopatienten. Darüber hinaus ist für eine optimale Patientenbetreuung wichtig, dass eine „nahtlose“ stationäre und ambulante Versorgungsstruktur gewährleistet wird. Bei Herzinsuffizienzpatienten müssen auch palliative Bedürfnisse berücksichtigt werden, die derzeit noch zu wenig Beachtung finden.
Literatur
1.
Zurück zum Zitat Angermann CE, Gelbrich G, Stork S et al (2007) Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). Eur J Heart Fail 9:1212–1222PubMedCrossRef Angermann CE, Gelbrich G, Stork S et al (2007) Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). Eur J Heart Fail 9:1212–1222PubMedCrossRef
2.
Zurück zum Zitat Angermann CE, Stork S, Gelbrich G et al (2012) Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail 5:25–35PubMedCrossRef Angermann CE, Stork S, Gelbrich G et al (2012) Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail 5:25–35PubMedCrossRef
3.
Zurück zum Zitat Anker SD, Comin Colet J, Filippatos G et al (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361:2436–2448 Anker SD, Comin Colet J, Filippatos G et al (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361:2436–2448
4.
Zurück zum Zitat Palliative Care Alliance and World Health Organization (2014) Global Atlas of Palliative Care at the End of Life Palliative Care Alliance and World Health Organization (2014) Global Atlas of Palliative Care at the End of Life
5.
Zurück zum Zitat World Health Organization (o J) WHO definition of palliative care World Health Organization (o J) WHO definition of palliative care
6.
Zurück zum Zitat Braunstein JB, Anderson GF, Gerstenblith G et al (2003) Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42:1226–1233 Braunstein JB, Anderson GF, Gerstenblith G et al (2003) Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42:1226–1233
7.
Zurück zum Zitat Brenner S, Guder G, Berliner D et al (2013) Airway obstruction in systolic heart failure – COPD or congestion? Int J Cardiol 168:1910–1916PubMedCrossRef Brenner S, Guder G, Berliner D et al (2013) Airway obstruction in systolic heart failure – COPD or congestion? Int J Cardiol 168:1910–1916PubMedCrossRef
8.
Zurück zum Zitat Cleland JG, Cohen-Solal A, Aguilar JC et al (2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360:1631–1639PubMedCrossRef Cleland JG, Cohen-Solal A, Aguilar JC et al (2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360:1631–1639PubMedCrossRef
9.
Zurück zum Zitat Ekman I, Chassany O, Komajda M et al (2011) Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study. Eur Heart J 32:2395–2404CrossRef Ekman I, Chassany O, Komajda M et al (2011) Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study. Eur Heart J 32:2395–2404CrossRef
10.
Zurück zum Zitat Faller H, Angermann CE (2008) Depression in chronic heart failure: complication, risk factor or autonomous disease? Internist (Berl) 49:394, 396–398, 400, 402–404 Faller H, Angermann CE (2008) Depression in chronic heart failure: complication, risk factor or autonomous disease? Internist (Berl) 49:394, 396–398, 400, 402–404
11.
Zurück zum Zitat Ghoorah K, Campbell P, Kent A et al (2014) Obesity and cardiovascular outcomes: a review. Eur Heart J Acute Cardiovasc Care (im Druck) Ghoorah K, Campbell P, Kent A et al (2014) Obesity and cardiovascular outcomes: a review. Eur Heart J Acute Cardiovasc Care (im Druck)
12.
Zurück zum Zitat Gielen S, Landmesser U (2014) The year in cardiology 2013: cardiovascular disease prevention. Eur Heart J 35:307–312CrossRef Gielen S, Landmesser U (2014) The year in cardiology 2013: cardiovascular disease prevention. Eur Heart J 35:307–312CrossRef
13.
Zurück zum Zitat Goodlin SJ (2009) Palliative care in congestive heart failure. J Am Coll Cardiol 54:386–396 Goodlin SJ (2009) Palliative care in congestive heart failure. J Am Coll Cardiol 54:386–396
14.
Zurück zum Zitat Hernandez AV, Usmani A, Rajamanickam A et al (2011) Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials. Am J Cardiovasc Drugs 11:115–128PubMedCrossRef Hernandez AV, Usmani A, Rajamanickam A et al (2011) Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials. Am J Cardiovasc Drugs 11:115–128PubMedCrossRef
15.
Zurück zum Zitat Jaarsma T, Beattie JM, Ryder M et al (2009) Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 11:433–443PubMedCrossRef Jaarsma T, Beattie JM, Ryder M et al (2009) Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 11:433–443PubMedCrossRef
16.
Zurück zum Zitat Klip IT, Comin-Colet J, Voors AA et al (2013) Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J 165:575–582.e573CrossRef Klip IT, Comin-Colet J, Voors AA et al (2013) Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J 165:575–582.e573CrossRef
17.
Zurück zum Zitat Krumholz HM, Baker DW, Ashton CM et al (2000) Evaluating quality of care for patients with heart failure. Circulation 101:E122–E140PubMedCrossRef Krumholz HM, Baker DW, Ashton CM et al (2000) Evaluating quality of care for patients with heart failure. Circulation 101:E122–E140PubMedCrossRef
18.
Zurück zum Zitat Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31:1281–1357 Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31:1281–1357
19.
Zurück zum Zitat McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803–869PubMedCrossRef McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803–869PubMedCrossRef
20.
Zurück zum Zitat McMurray JJ, Holman RR, Haffner SM et al (2010) Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 362:1477–1490 McMurray JJ, Holman RR, Haffner SM et al (2010) Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 362:1477–1490
21.
Zurück zum Zitat Neumann T, Biermann J, Erbel R et al (2009) Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int 106:269–275PubMedCentralPubMed Neumann T, Biermann J, Erbel R et al (2009) Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int 106:269–275PubMedCentralPubMed
22.
Zurück zum Zitat Silverberg DS, Wexler D, Iaina A et al (2006) The interaction between heart failure and other heart diseases, renal failure, and anemia. Semin Nephrol 26:296–306PubMedCrossRef Silverberg DS, Wexler D, Iaina A et al (2006) The interaction between heart failure and other heart diseases, renal failure, and anemia. Semin Nephrol 26:296–306PubMedCrossRef
23.
Zurück zum Zitat Solomon SD, Dobson J, Pocock S et al (2007) Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 116:1482–1487PubMedCrossRef Solomon SD, Dobson J, Pocock S et al (2007) Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 116:1482–1487PubMedCrossRef
24.
Zurück zum Zitat Stork S, Faller H, Schowalter M et al (2009) Evidence-based disease management in patients with heart failure (HeartNetCare-HF Würzburg). Dtsch Med Wochenschr 134:773–776PubMedCrossRef Stork S, Faller H, Schowalter M et al (2009) Evidence-based disease management in patients with heart failure (HeartNetCare-HF Würzburg). Dtsch Med Wochenschr 134:773–776PubMedCrossRef
25.
Zurück zum Zitat Stork S, Hense HW, Zentgraf C et al (2008) Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study. Eur J Heart Fail 10:1236–1245PubMedCrossRef Stork S, Hense HW, Zentgraf C et al (2008) Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study. Eur J Heart Fail 10:1236–1245PubMedCrossRef
26.
Zurück zum Zitat Swedberg K, Young JB, Anand IS et al (2013) Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med 368:1210–1219 Swedberg K, Young JB, Anand IS et al (2013) Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med 368:1210–1219
27.
Zurück zum Zitat Takeda A, Taylor SJ, Taylor RS et al (2012) Clinical service organisation for heart failure. Cochrane Database Syst Rev 9:CD002752PubMed Takeda A, Taylor SJ, Taylor RS et al (2012) Clinical service organisation for heart failure. Cochrane Database Syst Rev 9:CD002752PubMed
28.
Zurück zum Zitat Yancy CW, Jessup M, Bozkurt B et al (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128:e240–e327PubMedCrossRef Yancy CW, Jessup M, Bozkurt B et al (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128:e240–e327PubMedCrossRef
Metadaten
Titel
Ganzheitliche Behandlung der chronischen Herzinsuffizienz
verfasst von
C. Feldmann
G. Ertl
Prof. Dr. C.E. Angermann
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Die Innere Medizin / Ausgabe 6/2014
Print ISSN: 2731-7080
Elektronische ISSN: 2731-7099
DOI
https://doi.org/10.1007/s00108-013-3427-0

Weitere Artikel der Ausgabe 6/2014

Der Internist 6/2014 Zur Ausgabe

Einführung zum Thema

Herzinsuffizienz

Kongresse des BDI

BDI-Kongresse

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.